To corroborate these immunohistochemical staining results, we performed western blotting on breast cancer cell extracts, and confirmed the specificity of CB30 and COL-1 for CEACAM5 as well as the cross-reactivity of 1105 with CEACAM6 (Figure 1B). This evidence concerns the gene CEACAM6 and breast carcinoma.